newsfilter
← Latest News
GlobeNewswire·

AzurRx BioPharma Receives Approximately $550K for its 2020 CIR (French Research Tax Credit)

DELRAY BEACH, Fla., May 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), ("AzurRx" or the "Company"), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal